why choose us

First received: March 23, 2023

Clinical Trial: Optimizing CAB-LA as PrEP for Women Who Inject Drugs

Study Status: Completed

Recruit Status: RECRUITING

Condition: HIV Infections

Study Type: OBSERVATIONAL


Official Title: Exploring Engagement and Opportunities to Optimize CAB-LA as Pre-exposure Prophylaxis (PrEP) for Women Who Inject Drugs

Brief Summary: The goal of this study is to elicit information crucial for designing strategies to support engagement in cabotegravir, a long-acting injectable form of pre-exposure prophylaxis (PrEP) to reduce HIV risk among women who inject drugs (WWID), a population with high unmet need that has been understudied in all phases of PrEP research.The main questions this study aims to answer are:How do WWID perceive long-acting injectable cabotegravir (CAB-LA) as a HIV prevention tool?If and how their decisions to initiate CAB-LA…

Read more